Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CC2D2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LINC01020 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
HORMAD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ASIC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TGFB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LYPD4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CYP2C9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC01419 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BCORP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
SOWAHA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VWA3B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101928858 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IL1R2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM221 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IRAK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ASB17 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ITIH2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on